Evidence map›Paper›PMID 42883745›Full record

ReviewInternational journal of molecular sciences2026

Time to Heal: MicroRNA Temporal Dysregulation in Diabetic Foot Ulcers.

Lingyu Pan, Lingyun Zhao, Jinfeng Liu, You Mou, Kaili Wang, Xinyi Liu, Wei Hua

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lingyu PanDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.
Lingyun ZhaoDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.
Jinfeng LiuDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.
You MouDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.
Kaili WangDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.
Xinyi LiuDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.
Wei HuaDepartment of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0002-3061-5749

Funding

National Natural Science Foundation of China No. 82103767
6 · The paper itself

Abstract

Diabetic foot ulcers (DFUs) are a severe complication of diabetes characterized by delayed healing, infection susceptibility, and tissue necrosis. During normal healing, microRNA (miRNA) expression changes over time and helps regulate inflammation, tissue formation, and matrix remodeling. The same miRNA can serve opposing roles depending on cell type, timing, and wound context. Hyperglycemia, hypoxia, and oxidative stress disrupt these processes and prolong inflammation. This review examines how altered miRNA regulation may impair wound-healing transitions and vessel maturation in DFUs. We organize findings from experimental models and human samples into three interpretive patterns: delayed or insufficient induction, aberrant persistence, and temporal inversion or phase-inappropriate expression. Angiogenesis provides an example of how disrupted miRNA timing may impair vascular repair and granulation tissue formation. Circadian regulation may further influence these processes, although direct evidence linking circadian regulation, miRNA dynamics, and human DFUs remains limited. Preclinical studies of miRNA combinations, engineered vesicles, and biomaterial carriers suggest opportunities to coordinate local miRNA delivery with repair needs. The human studies reviewed here do not establish clinical efficacy of a defined miRNA mimic or inhibitor in DFUs. Further translation requires miRNA profiling over time, assessment of the wound's biological stage, and delivery to the relevant cells during the appropriate repair window.

Indexed as

Diabetic FootMicroRNAsWound HealingAnimalsGene Expression RegulationHumansMicroRNAsangiogenesischronobiologydiabetic foot ulcerextracellular vesiclesmetabolic inflammationmicroRNAtemporal regulationwound healing

Identifiers

PMID42883745
PMCPMC13665434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.